Nucor (NUE 151.78, +0.60, +0.4%): guides Q2 earnings above consensus; expects steel mills segment earnings to improve due to margin expansion
Cabot (CBT 70.19, -4.43, -5.9%): provides update on demand landscape: sales volumes are down in Performance Chemicals and Reinforcement Materials segments; withdraws FY23 EPS outlook
Humana (HUM 463.38, -0.47, -0.1%): reaffirms FY23 guidance; The Company will also reaffirm its full year Insurance segment benefit expense ratio guidance of 86.3 to 87.3 percent, although the Company now expects to be at the top end of this full year range